Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression

Silvana Gaudieri, D. De Santis, E. Mckinnon, C. Moore, D. Nolan, C.S. Witt, S.A. Mallal, Frank Christiansen

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Variation in the host response to infection by pathogens including HIV-1 may be conferred by polymorphic genetic factors such as HLA and killer immunoglobulin-like receptors (KIR) genes. Here, we examined KIR and HLA genotype effects on pretreatment viral load, rate of CD4(+) T-cell decline and progression to AIDS among adult HIV-1-infected patients within the Western Australian HIV Study Cohort. In this study, carriage of KIR genes within the 'B' haplotype (eg KIR2DS2) was specifically associated with a more rapid CD4(+) T-cell decline over time and progression to AIDS. In contrast, KIR gene repertoire had no effect on pretreatment viral load while selected HLA alleles ( eg HLA-B* 5701, HLA-B* 2705) demonstrated significant protective effects on viremia. Furthermore, interactions between specific HLA and KIR genes did appear to influence HIV disease progression. The results suggest that host genetic variation within the HLA and KIR gene complexes have clinically relevant effects on the course of HIV-1/AIDS, acting independently as well as synergistically to modify disease progression at multiple levels.
Original languageEnglish
Pages (from-to)online - approx 5-20pp
JournalGenes and Immunity
Volume6
DOIs
Publication statusPublished - 2005

Fingerprint Dive into the research topics of 'Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression'. Together they form a unique fingerprint.

Cite this